|
|
| Research article summary (published 30 May 1991): |
Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods and results in 24 patients.
Full Abstract
To define the role of stereotactic radiosurgery in the treatment of metastatic brain tumors we treated 24 consecutive patients (20 men, 4 women) with the 201-source 60Co gamma unit between May 1988 and March 1990. The primary tumors included malignant melanoma (n = 10), non-small cell lung carcinoma (n = 6), renal cell carcinoma (n = 3), colorectal carcinoma (n = 1), oropharyngeal carcinoma (n = 1), and adenocarcinoma of unknown origin (n = 3). All tumors were less than or equal to 3.0 cm in greatest diameter. Twenty patients received a planned combination of 30-40 Gy whole brain fractionated irradiation and a radiosurgical "boost" of 16-20 Gy to the tumor margins; one patient refused conventional fractionated irradiation. Three patients with recurrent, persistent, or new non-small cell lung carcinomas had radiosurgical treatment 12-20 months after receiving 30-42.5 Gy whole-brain external beam irradiation. Stereotactic computed tomographic imaging was used for target coordinate determination and imaging-integrated dose planning. All tumors were enclosed by the 50-90% isodose shell using one (n = 22), two (n = 1), or three (n = 1) irradiation isocenters. During this 23-month period (median follow-up of 7 months) no patient died from progression of a radiosurgically-treated brain metastasis. Ten patients died of systemic disease (n = 8) or remote central nervous system metastasis (n = 2) between 1 week and 10 months after radiosurgery. One patient had tumor progression and underwent craniotomy and tumor excision 5 months after radiosurgery. To date, median survival after radiosurgery has been 10 months; 1-year survival was 33.3%. Stereotactic radiosurgery eliminated the surgical and anesthetic risks associated with craniotomy and resection of solitary brain metastases. Radiosurgery also effectively controlled the growth of tumors considered "resistant" to conventional irradiation.
Author information
Author/s: Coffey, R J (RJ); Flickinger, J C (JC); Bissonette, D J (DJ); Lunsford, L D (LD);
Affiliation: Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905.
Journal and publication information
Publication Type: Journal Article
Journal: International journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys), published in UNITED STATES. (Language: eng)
Reference: 1991-Jun; vol 20 (issue 6) : pp 1287-95
Dates: Created 1991/07/18; Completed 1991/07/18; Revised 2004/11/17;
PMID: 1646195, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Cobalt Radioisotopes (0)Related articles
These are the most related articles currently in our database:
- Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.
25 Jun 2007 - Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone.
2 Sep 2007 - Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma.
30 Jan 2008 - Germline polymorphisms in EGFR and survival in patients with lung cancer receiving gefitinib.
20 Aug 2007 - [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]
30 Oct 2006 - [Comparison of computed tomography and magnetic resonance imaging to diagnose brain metastasis in non-small cell lung cancer]
30 Dec 2005 - Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.
30 Aug 2005 - Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
12 Nov 2005 - Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease.
30 Oct 2005 - Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer.
30 Aug 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.